Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 455.40
Bid: 456.70
Ask: 457.00
Change: 6.90 (1.54%)
Spread: 0.30 (0.066%)
Open: 455.60
High: 457.20
Low: 451.90
Prev. Close: 448.50
RTO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rentokil Tropical Plants

15 Mar 2007 07:02

Rentokil Initial PLC15 March 2007 15 March, 2007 RENTOKIL INITIAL DEVELOPS ITS TROPICAL PLANTS BUSINESS TO GEAR UP FOR GROWTH IN WORKPLACE ENVIRONMENTS MARKET Rentokil Tropical Plants, the world's largest provider of plants, replicafoliage and flowers for commercial environments, today announces a new globalbrand name, Ambius, and a development programme for the business. By the end of 2007, Ambius, which grew revenues by 4.1% to £106.6m in 2006, willhave a single global brand, greater market profile and additional revenuestreams through the expansion of its product range. The new brand will beofficially launched on 19 March. The UK will be the first market to experiencethe brand, followed by launches in 15 other countries across four continents. The new brand name will better reflect the company's extended service portfoliowhich will build on the company's 21 years' experience of designing, installingand servicing interior plants. The expanded product portfolio, to become available in all markets, will includethe provision of ambient scenting, corporate artwork and other products thatimprove workplace environments and employee well being. For instance, in the UK,the brand will shortly launch a range of 'acoustic artwork' which not onlyenhances office environments visually, but also dampens background noise in openplan offices, together enhancing the workplace for employees. The launch of the Ambius brand name is part of a programme to focus brandswithin the Rentokil Initial organisation on their core strengths. Today, theRentokil brand is focused on pest control, Initial is focused on cleaning andfacilities, and City Link is focused on parcel delivery. Doug Flynn, Chief Executive Officer, Rentokil Initial, comments: "This newinitiative will deliver a powerful and consistent brand presence, and introducea wider range of services to maximise its potential. In particular, Ambius willtarget those large scale international organisations which operate acrossborders. This is a market leading business and today's announcement is anotherexample of our company investing for growth." Jeff Mariola, Managing Director, Ambius, said: "As the market leader, Rentokilremains a strong brand for pest control but its association was not right forthe expert design and servicing of plants and other products which have provenbenefits in enhancing workplaces. "Fuelled by growing demand and interest in products that create harmoniousenvironments, we will begin offering these additional services to our 80,000+customer base. "A new global brand identity, that reflects our wider portfolio and accommodatesfuture growth, will help us to build on our market leading position in the USAto create an equally strong company in Europe." As part of the brand and product enhancements, Ambius will launch the division'sfirst global website (www.ambius.com), which will provide tailored country sitesin local languages under the umbrella of a global landing page. The brand willalso be directly communicated to customer audiences through the company'sparticipation in key events such as the RHS Chelsea Flower Show. Ends About Ambius Ambius is the world's largest single provider of plants, replica foliage andflowers for commercial environments. Ambius also offers a broad range ofproducts and services including ambient scenting, and artwork which can helpimprove employee productivity, reduce absentism and boost morale in theworkplace. Ambius is a division of Rentokil Initial plc (LSE: RTO). For more information, visit the new Ambius website at www.ambius.com. For further information, please contact: Malcolm Padley, Rentokil Initial, Corporate Communications - 020 7866 3027/07788 978 199 Tom Williams, Brunswick - 020 7396 5361 / 07834 502 361 Lexis PR Sara Barrow - 020 7908 6481/07771 520336 Jessica Gooch - 020 7908 6447/07970 152155 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
17th May 20243:30 pmRNSDirector/PDMR Shareholding
8th May 20242:00 pmRNSResult of AGM
29th Apr 20243:00 pmRNSHolding(s) in Company
23rd Apr 20249:30 amRNSHolding(s) in Company
18th Apr 20247:00 amRNSQ1 Trading Update
2nd Apr 20241:28 pmRNSBlock listing Interim Review
2nd Apr 202412:17 pmRNSTotal Voting Rights
27th Mar 202410:23 amRNSAnnual Financial Report
19th Mar 20242:05 pmRNSAdditional Listing
14th Mar 202410:19 amRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSFinal Results
1st Dec 20237:00 amRNSNorth American Management Changes
10th Nov 20232:28 pmRNSDirector/PDMR Shareholding
3rd Nov 20234:26 pmRNSHolding(s) in Company
3rd Nov 20234:22 pmRNSDirector/PDMR Shareholding
1st Nov 202312:50 pmRNSHolding(s) in Company
31st Oct 202311:45 amRNSHolding(s) in Company
30th Oct 20233:03 pmRNSDirector/PDMR Shareholding
30th Oct 202311:55 amRNSCredit rating update
19th Oct 20237:00 amRNSQ3 Trading Update
2nd Oct 202311:35 amRNSBlock listing Interim Review
27th Sep 20232:35 pmRNSDirector/PDMR Shareholding
1st Aug 202312:42 pmRNSDirector/PDMR Shareholding
27th Jul 20237:00 amRNS2023 Interim Results
29th Jun 20239:00 amRNSNotice of Management Presentation
23rd Jun 20235:58 pmRNSDirector/PDMR Shareholding
19th May 20233:03 pmRNSDirector/PDMR Shareholding
12th May 20239:09 amRNSDirector/PDMR Shareholding
11th May 20239:17 amRNSResult of AGM
28th Apr 202310:55 amRNSHolding(s) in Company
21st Apr 20232:41 pmRNSDirector/PDMR Shareholding
20th Apr 20237:00 amRNSQ1 Trading Update
4th Apr 20239:37 amRNSAnnual Financial Report
3rd Apr 202310:08 amRNSBlock listing Interim Review
23rd Mar 20239:42 amRNSDirector/PDMR Shareholding
20th Mar 20234:47 pmRNSDirector/PDMR Shareholding
16th Mar 20237:05 amRNSDirectorate Change
16th Mar 20237:00 amRNSFinal Results
9th Mar 20239:23 amRNSDirector Declaration
27th Feb 20238:55 amRNSNotice of Management Presentation
9th Nov 20224:33 pmRNSDirector Declaration
1st Nov 20222:25 pmRNSCorrection: Q3 Trading Update
1st Nov 20227:00 amRNSQ3 Trading Update
31st Oct 20224:03 pmRNSTotal Voting Rights
24th Oct 20225:15 pmRNSHolding(s) in Company
21st Oct 20224:42 pmRNSHolding(s) in Company
20th Oct 202212:35 pmRNSHolding(s) in Company
19th Oct 202211:43 amRNSHolding(s) in Company
18th Oct 20225:22 pmRNSHolding(s) in Company
17th Oct 20226:07 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.